Rome, backed by Arch and GV, hires science leaders to hit targets in “junk DNA”

Submitted by admin on July 19, 2021 - 11:02am

Source:

Fierce Biotech

News Tags:

Rome Therapeutics

junk DNA

cancer

autoimmune

Headline:

Rome, backed by Arch and GV, hires science leaders to hit targets in “junk DNA”

snippet:

Rome Therapeutics has appointed David Proia, Menachem Fromer and Sarah Knutson to its scientific leadership team. The trio join the Fierce 15 winner as it strives to develop cancer and autoimmune drugs against targets found in noncoding regions of the genome.

Search form

You are here

Rome, backed by Arch and GV, hires science leaders to hit targets in “junk DNA”

Rome, backed by Arch and GV, hires science leaders to hit targets in “junk DNA”